Courtney C Weber
Biographic Data
| ID | 7448036 |
|---|---|
| NAME | Courtney C Weber |
| GIVEN NAMES | Courtney C |
| FAMILY NAME | Weber |
| SIGNATURE | WEBER C C |
| AFFILIATIONS | Centre for Clinical Research in Emergency Medicine Harry Perkins Institute of Medical Research Perth Australia |
| ORCID | 0000-0003-1868-153X |
| VERIFIED | Yes |
| TOTAL WORKS | 8 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 8 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Novel benzodiazepines in illicit drug use
BACKGROUND: Novel or unregulated benzodiazepines are increasingly detected in illicit drug markets and may be perceived to pose greater clinical risk than regulated pharmaceutical benzodiazepines. However, much of the evidence underpinning these concerns derives from case reports, surveillance data, and settings characterised by extensive polysubstance exposure. We examined whether detection of novel/unregulated benzodiazepines is associated with…
Digital Detectives in the Making
Novel psychoactive substances in Australian emergency departments
Drug intelligence data generated in an acute harm setting such as the ED can provide early warning of drugs of concern circulating in the community, including NPS. This facilitates rapid community responses to reduce harm and inform subsequent public health responses
A multicentre case series of analytically confirmed gamma‐hydroxybutyrate intoxications in Western Australian emergency departments
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia
‘Trial by fire’
No prominent works on this page.
‘Trial by fire’
Characteristics and time course of benzodiazepine-type new psychoactive substance detections in Australia
A multicentre case series of analytically confirmed gamma‐hydroxybutyrate intoxications in Western Australian emergency departments
Novel psychoactive substances in Australian emergency departments
Drug intelligence data generated in an acute harm setting such as the ED can provide early warning of drugs of concern circulating in the community, including NPS. This facilitates rapid community responses to reduce harm and inform subsequent public health responses
Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments
Clinical toxicity of nitazene detections in two Australian emergency department toxicosurveillance systems
Novel benzodiazepines in illicit drug use
BACKGROUND: Novel or unregulated benzodiazepines are increasingly detected in illicit drug markets and may be perceived to pose greater clinical risk than regulated pharmaceutical benzodiazepines. However, much of the evidence underpinning these concerns derives from case reports, surveillance data, and settings characterised by extensive polysubstance exposure. We examined whether detection of novel/unregulated benzodiazepines is associated with…
Digital Detectives in the Making
Forensic Toxicology and Drug Analysis (7 works) · Medicine (5 works) · Emergency department (4 works) · Opioid Use Disorder Treatment (4 works) · Psychiatry (4 works) · Internal Medicine (3 works) · Medical emergency (3 works) · Poisoning and overdose treatments (3 works) · Benzodiazepine (2 works) · Drug (2 works)